Up to 8 Years Follow-up From RESONATE-2: First-Line Ibrutinib Treatment for Patients With Chronic Lymphocytic Leukemia

出版年份 2022 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages -

出版商

American Society of Hematology

发表日期

2022-04-05

DOI

10.1182/bloodadvances.2021006434

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now